Last updated: April 24, 2026

Application No. 18/719,590

Untitled Application

Unknown

Filed

1600

Examiner

AFREMOVA, VERA

Art Unit

1653

Tech Center

Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken

Assignee

Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken

OA Round

1 (Non-Final)

This examiner grants 51% of cases after interview

— +29.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 862 resolved cases, 2023–2026

Examiner Intelligence

AFREMOVA, VERA View full profile →

Grants 51% of resolved cases

Career Allow Rate

438 granted / 862 resolved

-9.2% vs TC avg

Strong +29% interview lift

Without

With

+29.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

65 currently pending

Career history

927

Total Applications

across all art units

Statute-Specific Performance

§101

9.0%

-31.0% vs TC avg

§103

37.3%

-2.7% vs TC avg

§102

23.5%

-16.5% vs TC avg

§112

23.6%

-16.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 862 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/273,004

Patent 12595454

METHODS OF CONTINUOUS CELL CULTURE

2y 5m to grant Granted Apr 07, 2026

18/025,944

Patent 12582682

PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF ACNE

2y 5m to grant Granted Mar 24, 2026

17/597,177

Patent 12576120

ANTIPROLIFERATIVE EFFECT OF AGAROPHYTON CHILENSIS EXTRACT IN PROSTATE CANCER

2y 5m to grant Granted Mar 17, 2026

16/302,624

Patent 12533392

COMPOSITIONS AND USES THEREOF

2y 5m to grant Granted Jan 27, 2026

18/459,983

Patent 12496318

Methods for Treating a Health Condition with Probiotics

2y 5m to grant Granted Dec 16, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

51%

Grant Probability

80%

With Interview (+29.4%)

3y 8m

Median Time to Grant

Low

PTA Risk

Based on 862 resolved cases by this examiner. Grant probability derived from career allow rate.